WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
maximize
Machine translation
67. (WO2010029174) METHOD FOR CLASSIFYING A CANCER PATIENT AS RESPONDER OR NON-RESPONDER TO IMMUNOTHERAPY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/029174    International Application No.:    PCT/EP2009/061888
Publication Date: 18.03.2010 International Filing Date: 14.09.2009
IPC:
C12Q 1/68 (2006.01)
Applicants: GLAXOSMITHKLINE BIOLOGICALS S.A. [BE/BE]; Rue de l'Institut 89 B-1330 Rixensart (BE) (For All Designated States Except US).
DUPONT, Pierre, Raphael [BE/BE]; (BE) (For US Only).
GAULIS, Swann, Romain, Jean-Thomas [FR/BE]; (BE) (For US Only).
HELLEPUTTE, Thibault, Marc [BE/BE]; (BE) (For US Only)
Inventors: DUPONT, Pierre, Raphael; (BE).
GAULIS, Swann, Romain, Jean-Thomas; (BE).
HELLEPUTTE, Thibault, Marc; (BE)
Agent: LOVATT, Victoria, Jayne; (GB)
Priority Data:
61/192,042 15.09.2008 US
0816867.6 15.09.2008 GB
Title (EN) METHOD FOR CLASSIFYING A CANCER PATIENT AS RESPONDER OR NON-RESPONDER TO IMMUNOTHERAPY
(FR) MÉTHODE
Abstract: front page image
(EN)Gene expression profiles, microarrays comprising nucleic acid sequences representing gene expression profiles, and new diagnostic kits and methods are provided. The kits and methods relate to the treatment of specific populations of, for example, cancer patients, as characterised by their gene expression profile, suffering from MAGE expressing tumours. A 33 gene expression signature identifies melanoma patients responding to treatment with MAGE-A3 ASCI.
(FR)L'invention porte sur des profils d'expression génique, des microréseaux comprenant des séquences d'acides nucléiques représentant des profils d'expression génique, et sur de nouveaux kits de diagnostic ainsi que sur des méthodes. Les kits et procédés portent sur le traitement de populations spécifiques, par exemple, de patients cancéreux, tels que caractérisés par leur profil d'expression génique, souffrant de tumeurs exprimant MAGE.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)